Back to Rankings

CRON

Cronos GroupF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
CRON vs peer average
15/100
CRON vs. peer average (F vs. C)
Grade spread
A 1 · B 3 · C 1 · D 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

XERS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.04B

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerXERSXeris Biopharma
CRON
Cronos Group
XERS
Xeris Biopharma
Grade
F
B
Momentum
31
36
Value
41
59
Sentiment
-
81
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs XERS

CRON / XERS
Grade Position
Below peers
CRON vs. peer average (F vs. C)
15/100
Momentum
31
XERS
Value
41
XERS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CRON
1
XERS
Xeris Biopharma Holdings Inc Common
B
80/100
-3
2
AKTS
Aktis Oncology Inc Common
N/A
-
-
3
ABSI
Absci Corp Common
D
40/100
-1
4
COLL
Collegium Pharmaceutical Inc Common
B
80/100
-3
5
DBVT
DBV Technologies SA ADR
B
80/100
-3
XERS is the first peer returned for this comparison set.